)

Lisata Therapeutics (LSTA) investor relations material
Lisata Therapeutics Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Executive summary
Achieved key clinical and corporate milestones, including new research agreements and strategic alliances in Q2 2025.
Focused on developing certepetide, a novel agent for solid tumors, with multiple ongoing global Phase 2 trials and promising preliminary results from ASCEND and iLSTA.
Leadership team has extensive biopharma experience; strategy includes pipeline advancement and out-licensing.
Cash runway extends into Q4 2026, supporting all current clinical programs through next data milestones.
Multiple ongoing and planned clinical studies with anticipated data-rich period over the next 12 months.
Financial highlights
Q2 2025 revenue was $70,000 from an upfront license agreement with Catalent; no revenue in Q2 2024.
Operating expenses decreased 10.6% year-over-year to $4.9M, mainly due to lower R&D and G&A costs.
Net loss for Q2 2025 was $4.7M, down from $5.0M in Q2 2024; net loss for six months was $9.4M, down from $10.4M.
Cash, equivalents, and marketable securities totaled $22M as of June 30, 2025, supporting operations into 2026.
Working capital was $20.6M and stockholders' equity was $21.0M at quarter end.
Outlook and guidance
Cash and marketable securities expected to fund operations for at least the next 12 months and into Q4 2026.
Anticipates a data-rich 12 months with several key clinical milestones and readouts from ASCEND, BOLSTER, CENDIFOX, and iLSTA trials.
Additional financing likely needed by late 2026 for long-term needs; company seeks non-dilutive funding and partnerships.
Ongoing clinical trials progressing as planned, but some new studies remain on hold to manage capital.
$10M milestone payment expected upon Qilu's progression of certepetide to Phase 3 in China.
Next Lisata Therapeutics earnings date

Next Lisata Therapeutics earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage